{"entity":{"type":"insider","cik":"0001640645","url":"/insider/0001640645","json_url":"/insider/0001640645.json","name":"O'Neil Thomas P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":8,"first":"2017-12-20","last":"2020-09-03","span_basis":"filed_date"},"name_variants":[{"name":"O'Neil Thomas P.","source":"filing","n_filings":8,"first_seen":"2017-12-20","last_seen":"2020-09-03"}],"transactions":[{"id":2825893,"accession":"0001567619-20-016411","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-016411","line_url":"/filing/0001567619-20-016411#line-2","is_derivative":false,"issuer_cik":"0001640645","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001640645","owner_cik":"0001640645","owner_name":"O'Neil Thomas P.","owner_display_name":"O'Neil Thomas P.","owner_url":"/insider/0001640645","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":22.1927,"price_display":"22.19","price_state":"stated","total_value":16644.525,"total_display":"16,644.52","total_whole":"16,645","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-01","filed_date":"2020-09-03","scope":"insider"},{"id":2164568,"accession":"0001567619-20-014527","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-014527","line_url":"/filing/0001567619-20-014527#line-2","is_derivative":false,"issuer_cik":"0001640645","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001640645","owner_cik":"0001640645","owner_name":"O'Neil Thomas P.","owner_display_name":"O'Neil Thomas P.","owner_url":"/insider/0001640645","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":25000.0,"total_display":"25,000.00","total_whole":"25,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-05","filed_date":"2020-08-07","scope":"insider"},{"id":3106625,"accession":"0001567619-20-012820","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001567619-20-012820","line_url":"/filing/0001567619-20-012820","is_derivative":false,"issuer_cik":"0001640645","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001640645","owner_cik":"0001640645","owner_name":"O'Neil Thomas P.","owner_display_name":"O'Neil Thomas P.","owner_url":"/insider/0001640645","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":26.6539174,"price_display":"26.65","price_state":"stated","total_value":26653.9174,"total_display":"26,653.92","total_whole":"26,654","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-02","scope":"insider","n_lines":3},{"id":3227438,"accession":"0001567619-20-012533","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-012533","line_url":"/filing/0001567619-20-012533#line-2","is_derivative":false,"issuer_cik":"0001640645","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001640645","owner_cik":"0001640645","owner_name":"O'Neil Thomas P.","owner_display_name":"O'Neil Thomas P.","owner_url":"/insider/0001640645","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2115.0,"shares_display":"2,115","price_per_share":35.2302,"price_display":"35.23","price_state":"stated","total_value":74511.873,"total_display":"74,511.87","total_whole":"74,512","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-23","filed_date":"2020-06-24","scope":"insider"},{"id":2531806,"accession":"0001567619-20-011564","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-011564","line_url":"/filing/0001567619-20-011564#line-2","is_derivative":false,"issuer_cik":"0001640645","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001640645","owner_cik":"0001640645","owner_name":"O'Neil Thomas P.","owner_display_name":"O'Neil Thomas P.","owner_url":"/insider/0001640645","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":25.3235,"price_display":"25.32","price_state":"stated","total_value":25323.5,"total_display":"25,323.50","total_whole":"25,324","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-01","filed_date":"2020-06-02","scope":"insider"},{"id":3106454,"accession":"0001567619-20-010950","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-010950","line_url":"/filing/0001567619-20-010950#line-2","is_derivative":false,"issuer_cik":"0001640645","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001640645","owner_cik":"0001640645","owner_name":"O'Neil Thomas P.","owner_display_name":"O'Neil Thomas P.","owner_url":"/insider/0001640645","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-20","filed_date":"2020-05-21","scope":"insider"},{"id":2074297,"accession":"0001567619-20-006202","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-006202","line_url":"/filing/0001567619-20-006202#line-2","is_derivative":false,"issuer_cik":"0001640645","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001640645","owner_cik":"0001640645","owner_name":"O'Neil Thomas P.","owner_display_name":"O'Neil Thomas P.","owner_url":"/insider/0001640645","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":27.678,"price_display":"27.68","price_state":"stated","total_value":27678.0,"total_display":"27,678.00","total_whole":"27,678","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-11","filed_date":"2020-03-12","scope":"insider"},{"id":5324465,"accession":"0001209191-17-066697","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-066697","line_url":"/filing/0001209191-17-066697#line-1","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001640645","owner_name":"O'Neil Thomas P.","owner_display_name":"O'Neil Thomas P.","owner_url":"/insider/0001640645","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"12/18/2017","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":160000.0,"total_display":"160,000.00","total_whole":"160,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-18","filed_date":"2017-12-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001692830","name":"Satsuma Pharmaceuticals, Inc.","url":"/issuer/0001692830","role":"Officer (Chief Financial Officer)","n_filings":7,"first_seen":"2020-03-12","last_seen":"2020-09-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001377121","name":"Protagonist Therapeutics, Inc","url":"/issuer/0001377121","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2017-12-20","last_seen":"2017-12-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001640645","retrieved_at":"2026-08-26T19:25:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}